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Introduction: Soft tissue myoepithelial carcinoma and myoepithelioma are rare entities, part of myoepithelial
tumors. They were incorporated into the World Health Organization classification of soft tissue tumors in 2002.
Here we present an exceptional case of myoepithelial carcinoma and myoepithelioma association. To the best of
our knowledge, such an association has never been reported in the literature.
Case presentation: We report a case of myoepithelial carcinoma combined with myoepithelioma occurring in
the soft tissue of the right forearm of an 84-year-old Arabian man. We describe the clinical, radiological and
pathological features dominated by histological polymorphism. We will also describe the proposed histological
criteria of malignancy and the major role of immunohistochemistry in positive and differential diagnosis. We finally
mention the therapeutic arsenal available.
Conclusion: Through this work, we report that myoepithelioma of soft tissue can progress to malignant
myoepithelioma.Introduction
Soft tissue myoepithelial (ME) carcinoma, also known as
soft tissue malignant myoepithelioma (STMM), and
myoepithelioma are rare entities, part of ME tumors.
They commonly occur in salivary glands, but they have
also been reported in the nasopharynx, larynx, breast
and lung [1,2]. Morphologically similar lesions arising
primarily in soft tissue and bone have been described in
the past 15 years [2]. They represent less than 1% of soft
tissue tumors [3]. In 1995, Burke et al. reported the first
primary myoepithelioma of soft tissue in retroperitoneal
localization [4]. In 2002, the World Health Organization
classification introduced ME tumors in soft tissue neo-
plasms. Hornick and Fletcher [5] published the largest
series in 2003 with 101 cases, in which they proposed
criteria for malignancy. Here, we present a case of ME
carcinoma and myoepithelioma association. To the best* Correspondence: ysf.mahdi@gmail.com
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never been reported in the literature.Case presentation
An 84-year-old Arabian man presented with a nodule of
the anterior surface of his right forearm present for 30
years which had progressively increased in size. He
benefited from resection of the nodule. Four months
later, the mass recurred at the same location, gradually
increased in volume and fistulated to his skin, causing a
total loss of function of his right arm. A physical exam-
ination revealed a firm and deeply adhering mass of
20×10cm, which was painful with inflammatory signs.
An X-ray of his arm showed no bone damage or soft tis-
sue calcifications (Figure 1). Magnetic resonance imaging
(MRI) revealed a heterogeneous tumor process in the an-
terior face of his right forearm measuring 13.7×5.5cm, iso-
signal at T1, slightly hypersignal at T2, including vascular
structures (Figure 1). As a result, a surgical biopsy was
performed.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Radiologic appearance of the tumor. a: Arm X-rays show opaque lesion involving the entire forearm. It was located in the soft tissue
without bone involvement. There was no calcification. b: Magnetic resonance imaging revealed an heterogeneous tumor process in the anterior
face of the right forearm.
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proliferation, made of both cellular and loose areas. The
neoplastic cells were epithelioid, plasmacytoid and spindle
(Figure 2a, b and c). They have frankly malignant cytomor-
phology with nuclear pleomorphism and vesicular chro-
matin (Figure 2d). Mitoses were numerous (Figure 2d),
estimated at 10 mitoses per 10 high-power fields. The
matrix was myxoid, with metaplastic bone (Figure 3).
Areas of necrosis were observed. ImmunohistochemistryFigure 2 Features of malignant myoepithelioma on histological exam
epithelioid (a), plasmacytoid (b), and spindle (c). They have frankly maligna
chromatin (d). Mitoses were numerous (d, arrows).revealed positive staining with pancytokeratin, epithelial
membrane antigen (EMA) and S-100 (Figure 4). The
tumor was immunonegative for desmin, smooth muscle
actin and CD34. A diagnosis of malignant myoepithe-
lioma was established. EWSR1 gene rearrangement re-
search was non-contributory.
Given the locally advanced stage of the disease, an am-
putation of the limb was performed. An examination re-
vealed the presence of a very limited and encapsulatedination (hematoxylin and eosin staining). The neoplastic cells were
nt cytomorphology with nuclear pleomorphism and vesicular
Figure 3 Features of malignant myoepithelioma on histological examination (hematoxylin and eosin staining). The matrix was myxoid
(a), with metaplastic bone (b).
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epithelioid without cytological atypia, realizing myoe-
pithelioma (Figure 5).
Discussion
The histogenesis of soft tissue ME tumors is unknown,
since normal ME cells are not found at these sites [2]. A
few reports of genetic abnormalities have indicated
EWSR1 gene rearrangement in soft tissue ME tumors
and, in one case each, the fusion partner was identified
as either PBX1 or ZNF444 [6]. In a recent study of
Antonescu et al. [6], 66 ME tumors mainly from soft tissue
(71%), but also from skin, bone and visceral locations,Figure 4 Immunohistochemical profile of malignant myoepithelioma. T
as well. They were positive for pancytokeratin (AE1/AE3) (a), S-100 protein (b)
which eliminated diagnosis of rhabdomyosarcoma.characterized by classic morphological features and sup-
porting immunoprofile were studied. The results do not
support a pathogenetic relationship between soft tissue
ME tumors and their salivary gland counterparts [6].
EWSR1 gene rearrangement was a common event in ME
tumors arising outside salivary glands, found in 45% of
cases. EWSR1-POU5F1 fusion was identified in a young
patient, and in a subset of soft tissue ME tumors with clear
cell morphology, which can be used as a molecular diag-
nostic test in difficult cases. EWSR1-PBX1 fusion was
found in a subset of ME tumors associated with a bland
sclerotic appearance or clear cell morphology. EWSR1-
ZNF444 fusion was present in one case of ME tumors.he neoplastic cells have epithelial and myoepithelial immunophenotype
and epithelial membrane antigen (c). They were negative for desmin (d),
Figure 5 Features of myoepithelioma on histological examination (hematoxylin and eosin staining). Extensive sampling of the tumors
reveals a very limited and encapsulated nodule (a). It was highly cellular, demonstrating a solid growth pattern without stromal component. The
neoplastic cells were only epithelioid. They show no cytological atypia (b).
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cially located, and showed ductal differentiation. By
contrast, one report describes a rare case of STMM
without EWSR1 gene rearrangement and an unusually
poor outcome [7]: a 26-year-old man with STMM in his
right hip. The tumor did not have an EWSR1 gene re-
arrangement. It behaved aggressively and the patient
died from multiple metastases 18 months after diagno-
sis. In another case of ME tumor in the pelvis of a 26-
year-old man, considered as unresectable, EWSR1-ATF1
fusion was identified, extending the spectrum of partner
genes of EWSR1 [8].
The age of patients in whom ME tumors present in
soft tissue ranges from 3 to 83 years, with a mean of 40
years and a slight male predilection (1.4:1) [1,2,5]. Most
patients present with a painful or painless mass [1]. The
duration of symptoms ranges from 2 weeks to 20 years
[1]. Nearly two-thirds of reported cases have arisen on
the extremities (38% lower extremity and 27% upper ex-
tremity); the remainder has involved the head and the
neck region (16%), trunk (13%) and visceral soft tissue
(6%) [2]. Approximately 60% of tumors are subcutane-
ous in origin and 40% occur in deep soft tissue (intra-
muscular or subfascial) [2].
MRI is the radiological technique of choice [3]. In fact,
it allows suspecting the diagnosis, and looking for a pos-
sible bone involvement in specifying the type (extension
or pressure of the bone) [3].
The mean size for benign tumors is 4cm (range, 0.7 to
12cm) compared with 6cm (range, 1.3 to 20cm) for ma-
lignant lesions [2]. Most cases of soft tissue ME tumors
are grossly well circumscribed [2,4], and may have a
multinodular appearance [2].
On histological examination, the cells are most com-
monly arranged in trabecular or reticular patterns, but
nested and solid areas are also frequently seen [2]. They
can take on various morphological appearances, inclu-
ding spindled, epithelioid, plasmacytoid or clear cellfeatures [2,5,9]. Typically, the epithelioid cells are
present in combination with one or more other ME cell
types [2]. The matrix is characteristically myxoid, chon-
dromyxoid or hyalinized; metaplastic cartilage and/or
bone are found in 15 to 20% of cases [2]. Squamous dif-
ferentiation may be seen [9]. Of STMM, 40% show at
least focal tumor necrosis [2]. According to the series of
Hornick and Fletcher, infiltrative tumor margins and in-
creased mitotic rates were frequently seen, but did not
correlate to malignant behavior [5]. The only histo-
logical feature significantly associated with recurrence
or metastasis was moderate or severe cytological atypia,
which was defined by vesicular or coarse chromatin,
prominent often large nucleoli, or nuclear pleomorphism
[5]. On immunohistochemical examination, the neoplastic
ME cells express the epithelial markers AE1/AE3 (90%)
and EMA (60%); and they express the ME markers S-100
protein (89%), calponin (87%), glial fibrillary acidic protein
(GFAP;46%), and smooth muscle actin (36%) [1].
Due to histological polymorphism, STMM poses sig-
nificant challenges in differential diagnosis. This in-
cludes entities having architectural and cytological
features similar to those of STMM, and sharing positiv-
ity of some antibodies in immunohistochemistry. This
primarily involves epithelioid malignant peripheral
nerve sheath tumor (MPNST), high-grade extraskeletal
myxoid chondrosarcoma (EMC), epithelioid sarcoma,
metastatic carcinoma and metastatic melanoma [2]. In
addition to clinical data and histology, immunohisto-
chemistry is often necessary. High-grade EMC are uni-
formly negative for keratin, and GFAP expression is rare
[2]. Epithelioid MPNST generally do not express epithe-
lial markers [2]. In addition, many epithelioid MPNSTs
show foci of conventional spindle cell MPNST and a
nerve of origin or a pre-existing benign nerve sheath
tumor can be identified [2]. For proximal-type epitheli-
oid sarcoma, S-100 expression is rare and GFAP is nega-
tive [2]. In sclerosing epithelioid fibrosarcoma, keratin
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and GFAP expression and the lack of epithelial markers
allow exclusion of metastatic carcinoma or melanoma re-
spectively [2]. The use of a complete immunohistochemi-
cal panel is critical. In our case, it was key to the positive
diagnosis. In fact, if the antibody anti-S-100 protein was
not done, we would not have made the diagnosis of ME
carcinoma on biopsy.
Complete surgical resection with negative margins is the
recommended treatment [1,2]. For metastatic STMM,
experience with chemotherapy and radiation therapy is
limited. The first reported case of a complete patho-
logical response was a 37-year-old woman with meta-
static STMM of the vulva in 2006 [10]. She received
paclitaxel-carboplatin combination chemotherapy with
a complete pathological response, and no further recur-
rence for more than 3 years.
Conclusions
In our case, we had a tumor of soft parts which was lo-
cally invasive. Diagnosis of STMM was established in
view of a wide variation in cellular morphology, severe
cytological atypia, and epithelial and ME immunopheno-
type. It developed on myoepithelioma after the first sur-
gery. Through this work, we report that myoepithelioma
of soft tissue can progress to malignant myoepithelioma.
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